Summary

Cardiovascular Health Supplements Market Growth & Trends

The global cardiovascular health supplements market size is anticipated to reach USD 21.54 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 9.06% from 2023 to 2030. Factors such as rising awareness about healthcare, a growing population suffering from cholesterol, obesity, cardiovascular disease, and poor dietary habits are driving the demand for cardiovascular supplements over the forecast period. According to World Heart Federation, every year globally approximately 4.4 million people die due to high cholesterol. Supplements like plant sterols or stanols can help lower LDL (bad) cholesterol levels by interfering with cholesterol absorption in the intestines. This can contribute to a lower risk of atherosclerosis (hardening of the arteries).

Consumers are becoming more interested in healthy diets and lifestyle modifications as they become more aware of high-quality foods that contribute to excellent well-being and include nutritional value. Obesity is becoming a growing concern for today's consumers, owing mostly to sedentary lifestyles and poor eating habits. As a result, there is an increased need for supplements that provide significant health benefits, thereby contributing to the prevention of heart disease. Cardiovascular health supplements, in this way, meet consumer demand by delivering heart health support as well as other critical nutrients for general health.

One notable trend in the market is the increasing preference for natural and plant-based ingredients. Consumers are looking for products that are free from artificial additives and chemicals, such as supplements containing plant sterols and phytosterols. Omega-3 fatty acids, found in fish oil supplements, continue to be a popular choice for heart-related problems. Research has consistently shown their benefits in reducing the risk of heart disease. Moreover, personalized supplements are gaining traction, with companies offering tailored solutions based on individual health profiles and genetic factors. This trend allows consumers to address specific cardiovascular health needs more effectively.

Growing startups, investments, and funding by market players to expand their nutritional platforms are expected to drive market growth over the coming years. For instance, in December 2022, HealthKart raised a total of USD 135 million in funding led by Temasek. The funding helps the company to expand its online and offline presence worldwide.

Cardiovascular Health Supplements Market Report Highlights

• Based on type, the natural supplements segment held the largest market share of 69.29% in 2022 and is expected to maintain its significance over the forecast period. This is attributed to the rising health awareness and shift toward plant-based and vegetarian diets

• Among the ingredients, the omega fatty acids segment held the largest market share of 26.96% in 2022. In contrast, the herbs & botanicals segment is expected to grow at the fastest CAGR over the forecast period, owing to the rising consumer preference for natural and holistic approaches to health and wellness

• Based on form, the softgels segment held the largest market share of 36.62% in 2022. On the other hand, the capsules segment is anticipated to grow at the fastest CAGR over the coming years, owing to its capability to dissolve faster than other forms in the human body

• Based on the distribution channel, the offline segment dominated the market in 2022 with the largest market share of 70.67%. In contrast, the online segment is projected to register the fastest CAGR during the projected period, due to the increasing penetration of online channels as they can reach a wider audience

• In terms of region, Asia Pacific dominated the market in 2022 with a revenue share of 38.40%, owing to the increasing prevalence of cardiovascular disease and increasing recognition of supplements to improve overall heart health. Europe is expected to grow at the second fastest CAGR over the coming years, due to the rising preference for dietary supplements

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Ingredient Segment
1.2.3. Form Segment
1.2.4. Distribution Channel Segment
1.3. Information Analysis
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing
1.6. Research Assumptions
1.7. Information Procurement
1.7.1. Primary Research
1.8. Information or Data Analysis
1.9. Market Formulation & Validation
1.10. Market Model
1.11. Global Market: CAGR Calculation
1.12. Objectives
1.12.1. Objective 1
1.12.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Prevalence Of Cardiovascular Diseases
3.2.1.2. Rising Adoption Of Natural Or Plant-Based Products
3.2.1.3. Increasing Accessibility Of Supplements
3.2.2. Market Restraint Analysis
3.2.2.1. Increasing Regulations In The Supplements Industry
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Cardiovascular Health Supplements Market: Type Movement Analysis
4.2. Natural Supplements
4.2.1. Natural Supplements Market, 2018 - 2030 (USD Million)
4.3. Synthetic Supplements
4.3.1. Synthetic Supplements Market, 2018 - 2030 (USD Million)
Chapter 5. Ingredient Business Analysis
5.1. Cardiovascular Health Supplements Market: Ingredient Movement Analysis
5.2. Vitamins & Minerals
5.2.1. Vitamins & minerals market, 2018 - 2030 (USD Million)
5.3. Herbs & Botanicals
5.3.1. Herbs & botanicals market, 2018 - 2030 (USD Million)
5.4. Omega Fatty Acids
5.4.1. Omega fatty acids market, 2018 - 2030 (USD Million)
5.5. Coenzyme Q10 (CoQ10)
5.5.1. Coenzyme Q10 (CoQ10) market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others market, 2018 - 2030 (USD Million)
Chapter 6. Form Business Analysis
6.1. Cardiovascular Health Supplements Market: Form Movement Analysis
6.2. Liquids
6.2.1. Liquids Market, 2018 - 2030 (USD Million)
6.3. Tablets
6.3.1. Tablets Market, 2018 - 2030 (USD Million)
6.4. Capsules
6.4.1. Capsules Market, 2018 - 2030 (USD Million)
6.5. Softgels
6.5.1. Softgels Market, 2018 - 2030 (USD Million)
6.6. Powders
6.6.1. Powders Market, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Other Formulations Market, 2018 - 2030 (USD Million)
Chapter 7. Distribution Channel Business Analysis
7.1. Cardiovascular Health Supplements Market: Distribution Channel Movement Analysis
7.2. Offline
7.2.1. Offline Market, 2018 - 2030 (USD Million)
7.3. Online
7.3.1. Online Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Cardiovascular Health Supplements Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Target Disease Prevalence
8.2.2.4. Regulatory Framework
8.2.2.5. U.S. Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Target Disease Prevalence
8.2.3.4. Regulatory Framework
8.2.3.5. Canada Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Target Disease Prevalence
8.3.2.4. Regulatory Framework
8.3.2.5. UK Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Target Disease Prevalence
8.3.3.4. Regulatory Framework
8.3.3.5. Germany Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Target Disease Prevalence
8.3.4.4. Regulatory Framework
8.3.4.5. France Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Target Disease Prevalence
8.3.5.4. Regulatory Framework
8.3.5.5. Italy Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Target Disease Prevalence
8.3.6.4. Regulatory Framework
8.3.6.5. Spain Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Target Disease Prevalence
8.3.7.4. Regulatory Framework
8.3.7.5. Denmark Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Target Disease Prevalence
8.3.8.4. Regulatory Framework
8.3.8.5. Sweden Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Target Disease Prevalence
8.3.9.4. Regulatory Framework
8.3.9.5. Norway Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Target Disease Prevalence
8.4.2.4. Regulatory Framework
8.4.2.5. Japan Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Target Disease Prevalence
8.4.3.4. Regulatory Framework
8.4.3.5. China Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Target Disease Prevalence
8.4.4.4. Regulatory Framework
8.4.4.5. India Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Target Disease Prevalence
8.4.5.4. Regulatory Framework
8.4.5.5. Australia Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Target Disease Prevalence
8.4.6.4. Regulatory Framework
8.4.6.5. Thailand Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Target Disease Prevalence
8.4.7.4. Regulatory Framework
8.4.7.5. South Korea Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Target Disease Prevalence
8.5.2.4. Regulatory Framework
8.5.2.5. Brazil Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Target Disease Prevalence
8.5.3.4. Regulatory Framework
8.5.3.5. Mexico Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Target Disease Prevalence
8.5.4.4. Regulatory Framework
8.5.4.5. Argentina Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Target Disease Prevalence
8.6.2.4. Regulatory Framework
8.6.2.5. South Africa Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Target Disease Prevalence
8.6.3.4. Regulatory Framework
8.6.3.5. Saudi Arabia Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Target Disease Prevalence
8.6.4.4. Regulatory Framework
8.6.4.5. UAE Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Target Disease Prevalence
8.6.5.4. Regulatory Framework
8.6.5.5. Kuwait Cardiovascular Health Supplements Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2022
9.4. Company Profiles
9.4.1. NOW Health Group, Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Bright Lifecare Pvt Ltd (Truebasics.com)
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Natural Organics, Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. DaVinci Laboratories of Vermont
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Nordic Naturals
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Thorne HealthTech, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Nestle (Pure Encapsulations, LLC.)
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Amway
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. InVite Health
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. GNC Holdings, LLC
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives